Skip to main content

Stoneshield Capital to acquire 15% stake in Exolum from OMERS

LUXEMBOURG, May 22, 2026 (GLOBE NEWSWIRE) — Stoneshield Capital today announced that it has signed an agreement to acquire a 15% stake in Exolum from OMERS, building on its existing investment in the company since January 2026. The remaining 10% of OMERS ~25% stake is separately being acquired by a leading global investment firm with over $100 billion in assets under management. OMERS, together with its investment partners, has been invested in Exolum since 2016. Terms of the transactions are not being disclosed. Exolum is a Spanish-headquartered global energy logistics company specialising in the transportation, storage and distribution of refined products, bulk liquids and aviation fuels, while playing an increasingly important role in supporting the energy transition. Exolum owns a 4,000km transmission pipeline network in Spain...

Continue reading

DTC Acquires Adaptive Dynamics to Enhance Mission-Critical Communications

Ashburn, Virginia, May 22, 2026 (GLOBE NEWSWIRE) — DTC, a Codan company (DTC) and a provider of advanced tactical communications systems, today announced the acquisition of Adaptive Dynamics, Inc., a U.S.-based firm specializing in anti-jamming and interference mitigation technologies for mission-critical communications and Assured Positioning Navigation and Timing.  Adaptive Dynamics brings over two decades of experience in the development of advanced algorithms and RF technologies designed to maintain communications performance in congested and contested electromagnetic environments. Its capabilities include intentional and unintentional interference cancellation, signal enhancement, and adaptive filtering techniques applicable to defense and national security systems.  The acquisition augments DTC’s strategic objective to enhance...

Continue reading

Form 8.3 – Advanced Medical Solutions Group plc – Octopus

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Full name of discloser: OCTOPUS INVESTMENTS LTD(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Advanced Medical Solutions Group plc(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)        Date position...

Continue reading

Cycurion Acquires Secuvant, Supercharging AI-Driven Cybersecurity with Automated, Scalable Threat Defense – Perfectly Complements HavenX Platform

MCLEAN, Va., May 22, 2026 (GLOBE NEWSWIRE) — Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a leading provider of AI-driven cybersecurity, IT security solutions, and managed services, today announced the acquisition of Secuvant, LLC (“Secuvant”), a premier provider of enterprise-grade cybersecurity and risk management services. This strategic move dramatically strengthens Cycurion’s MDR, threat and vulnerability management, and compliance capabilities — delivering immediate firepower for mid-market and enterprise clients in construction, agriculture, financial services, utilities, manufacturing, and critical infrastructure. The transaction is expected to contribute approximately $3 million in annualized revenue and approximately $1.5 million in EBITDA for fiscal year 2026. Strategic SynergiesSecuvant’s expertise in...

Continue reading

Apollo Group signed an acquisition agreement for Lithuanian catering companies

22.05.2026 Apollo Group OÜ signed a share purchase agreement with Defood OÜ (registration code 171141185), by which Apollo Group OÜ will acquire 100% of the shares in the Lithuanian companies RESTORANI DVYLIKA UAB (Lithuanian registration code 307089481) for a price of 5,067,154 euros and CCF KAVINĖS UAB (Lithuanian registration code 307088123) for a price of 272,631 euros. The transaction, including the payment of the price, is subject to the necessary approval from the Lithuanian Competition Authority and the additional customary formalities. The transaction is in line with Apollo Group’s long-term growth goals and strategic expansion plans. This is an important strategic step that strengthens Apollo Group’s position in the Lithuanian market, adds a new restaurant format to the group’s portfolio and creates additional operational synergies. Currently,...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 21 05 2026] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Form 8.3 – [ANIMALCARE GROUP PLC – 21 05 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ANIMALCARE GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Equans announces completion of the sale of its EV charging concessions in the Netherlands

PRESS RELEASE              Paris, 22 May 2026 Equans announces completion of the sale of its EV charging concessions in the Netherlands In line with the commitments it made at its Capital Markets Day 2023, Equans, a global leader in the Energy and Services sector and a subsidiary of the Bouygues Group, announces that it has completed, on May 18th, the sale of Equans Infra & Mobility (I&M), the entity holding its EV charging concessions in the Netherlands. The buyer of I&M is an entity controlled by DigitalBridge and Aberdeen Investments. They will continue to procure funding to accelerate the growth of the business in a rapidly evolving market environment. This divestment is part of Equans strategic plan, presented on February 23, 2023, at its Capital Markets Day, which includes the disposal of asset-based activities. As...

Continue reading

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services OrganizationTevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services OrganizationWARREN, N.J., May 21, 2026 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent (“LoI”) to evaluate a potential transaction with a Management Services Organization (“MSO”). If consummated, the proposed transaction could expand Tevogen’s healthcare infrastructure capabilities and support the Company’s evolution into a revenue-generating healthcare enterprise comprised of Tevogen Bio, its biotechnology arm; Tevogen.AI, its technology arm; and, subject to completion of proposed transactions, a healthcare...

Continue reading

Numero AI and Royu Merge to Redefine How Finance Teams Operate

Two AI-first fintech companies are joining forces to reshape the Office of the CFO. The deal combines finance domain expertise with large-scale platform engineering, expanding Numero’s agentic system of work across close, reconciliation, reporting, order-to-cash, and technical accounting workflows.        Photo courtesy of Viswajith Vishwaa PALO ALTO, Calif., May 21, 2026 (GLOBE NEWSWIRE) — Numero AI today announced the acquisition of Royu in an undisclosed cash-and-stock transaction, bringing together two AI-first companies with a shared vision to help controllers and finance teams build leaner, more efficient operations. The acquisition reflects the accelerating market demand for agentic platforms purpose-built for enterprise finance workflows and marks one of the fastest early-stage acquisitions in the AI-driven finance...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.